Phone app could revolutionize MS monitoring
NCT ID NCT05009160
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether smartphone-based challenges and surveys can reliably measure multiple sclerosis (MS) progression. Researchers will compare these digital biomarkers with standard clinical exams, brain scans, and lab tests in 300 people with MS over two years. The goal is to develop more frequent, convenient, and sensitive ways to track the disease and guide treatment decisions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Sclerosi Multipla, Ospedale Regionale di Lugano
Lugano, Switzerland, Switzerland
-
Department of Neurology, CHUV Lausanne
Lausanne, Switzerland, Switzerland
-
Klinik für Neurologie, Kantonsspital St. Gallen
Sankt Gallen, Switzerland, Switzerland
-
Klinik für Neurologie, Universitätsspital Zürich
Zurich, Switzerland, Switzerland
-
MS Center, Department of Neurology University Hospital Basel
Basel, Switzerland
-
Neurozentrum, Kantonsspital Aarau
Aarau, Switzerland, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we decode the different types of pain in multiple sclerosis?
- Can a blood pressure pill slow MS disability?
- Hidden MS progression: can brain scans and blood tests predict it?
- Can Brain-Training apps fix sleep in MS?
- Can an Iron-Based dye reveal hidden inflammation in progressive MS?
- Strumming for the brain: could ukulele lessons sharpen minds in MS?